3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Conditions
Motor Activity
9
Polycystic Ovary Syndrome
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Obesity
5
Weight Loss
4
Neoplasms
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Endometrial Neoplasms
3
Overweight
2
Multiple Endocrine Neoplasia Type 1
2
Malnutrition
2
Lymphoma, Follicular
2
Carcinoma, Intraductal, Noninfiltrating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Medical Oncology
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cyclophosphamide
22
fludarabine phosphate
17
Cyclosporine
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Filgrastim
14
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
11
Antilymphocyte Serum
11
Radiotherapy
8
Melphalan
8
Exercise
8
Dexamethasone
8
Cytarabine
8
Asparaginase
8
venetoclax
7
blinatumomab
7
Vincristine
7
Etoposide
7
Daunorubicin
7
fludarabine
6
Methylprednisolone
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
Therapeutics
5
Psychiatric Rehabilitation
5
Prednisone
4
Immunotherapy, Adoptive
4
Cord Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Diet
×
Clear all
NCT06846294
2025-02-26
BREVARY
University of Exeter
Phase NA
Not yet recruiting
90 enrolled